These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38503845)

  • 1. No adverse association between exercise exposure and diffuse myocardial fibrosis in male endurance athletes.
    Andresen K; Klæboe LG; Lie ØH; Broch K; Kvaslerud AB; Bosse G; Hopp E; de Lange C; Haugaa KH; Edvardsen T
    Sci Rep; 2024 Mar; 14(1):6581. PubMed ID: 38503845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes.
    Domenech-Ximenos B; Sanz-de la Garza M; Prat-González S; Sepúlveda-Martínez A; Crispi F; Duran-Fernandez K; Perea RJ; Bijnens B; Sitges M
    J Cardiovasc Magn Reson; 2020 Sep; 22(1):62. PubMed ID: 32878630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
    Ntusi NA; Piechnik SK; Francis JM; Ferreira VM; Rai AB; Matthews PM; Robson MD; Moon J; Wordsworth PB; Neubauer S; Karamitsos TD
    J Cardiovasc Magn Reson; 2014 Mar; 16(1):21. PubMed ID: 24593856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Fibrosis in Competitive Triathletes Detected by Contrast-Enhanced CMR Correlates With Exercise-Induced Hypertension and Competition History.
    Tahir E; Starekova J; Muellerleile K; von Stritzky A; Münch J; Avanesov M; Weinrich JM; Stehning C; Bohnen S; Radunski UK; Freiwald E; Blankenberg S; Adam G; Pressler A; Patten M; Lund GK
    JACC Cardiovasc Imaging; 2018 Sep; 11(9):1260-1270. PubMed ID: 29248656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.
    Ide S; Riesenkampff E; Chiasson DA; Dipchand AI; Kantor PF; Chaturvedi RR; Yoo SJ; Grosse-Wortmann L
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):10. PubMed ID: 28143545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.
    Yang D; Li X; Sun JY; Cheng W; Greiser A; Zhang TJ; Liu H; Wan K; Luo Y; An Q; Chung YC; Han Y; Chen YC
    J Cardiovasc Magn Reson; 2018 Sep; 20(1):69. PubMed ID: 30257686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes.
    Wilson M; O'Hanlon R; Prasad S; Deighan A; Macmillan P; Oxborough D; Godfrey R; Smith G; Maceira A; Sharma S; George K; Whyte G
    J Appl Physiol (1985); 2011 Jun; 110(6):1622-6. PubMed ID: 21330616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis.
    Giollo A; Dumitru RB; Swoboda PP; Plein S; Greenwood JP; Buch MH; Andrews J
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1053-1062. PubMed ID: 33057879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
    Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy.
    Sunthankar SD; George-Durrett K; Crum K; Slaughter JC; Kasten J; Raucci FJ; Markham LW; Soslow JH
    J Cardiovasc Magn Reson; 2023 Jul; 25(1):44. PubMed ID: 37517994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
    Al-Wakeel-Marquard N; Seidel F; Herbst C; Kühnisch J; Kuehne T; Berger F; Klaassen S; Messroghli DR
    Int J Cardiol; 2021 Jun; 333():219-225. PubMed ID: 33737165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
    Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.
    Neilan TG; Coelho-Filho OR; Shah RV; Abbasi SA; Heydari B; Watanabe E; Chen Y; Mandry D; Pierre-Mongeon F; Blankstein R; Kwong RY; Jerosch-Herold M
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):672-83. PubMed ID: 23643283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
    Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular diastolic filling patterns in competitive triathletes with and without myocardial fibrosis by cardiac magnetic resonance time-volume analysis.
    Chen H; Jungesblut J; Saering D; Muellerleile K; Beitzen-Heineke A; Harms P; Erley J; Schoennagel B; Schneider JN; Cavus E; Fischer R; Lund GK; Adam G; Tahir E
    Eur J Radiol; 2023 Jan; 158():110615. PubMed ID: 36434969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
    Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
    Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and pattern of focal and potential diffuse myocardial fibrosis in male and female marathon runners using contrast-enhanced cardiac magnetic resonance.
    Ragab H; Lund GK; Breitsprecher L; Sinn MR; Muellerleile K; Cavus E; Stehning C; Tahir E; Blankenberg S; Patten M; Pressler A; Adam G; Avanesov M
    Eur Radiol; 2023 Jul; 33(7):4648-4656. PubMed ID: 36683089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Diffuse Ventricular Myocardial Fibrosis Using Native T1 in Children With Repaired Tetralogy of Fallot.
    Yim D; Riesenkampff E; Caro-Dominguez P; Yoo SJ; Seed M; Grosse-Wortmann L
    Circ Cardiovasc Imaging; 2017 Mar; 10(3):. PubMed ID: 28292861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.